Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).
about
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.Immune checkpoints and their inhibition in cancer and infectious diseases.Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.Immune checkpoint blockade in infectious diseases.Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV
P2860
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Programed death-1/programed de ...... med death-ligand 1 (Avelumab).
@en
Programed death-1/programed de ...... anti-programed death-ligand 1
@nl
type
label
Programed death-1/programed de ...... med death-ligand 1 (Avelumab).
@en
Programed death-1/programed de ...... anti-programed death-ligand 1
@nl
prefLabel
Programed death-1/programed de ...... med death-ligand 1 (Avelumab).
@en
Programed death-1/programed de ...... anti-programed death-ligand 1
@nl
P2093
P2860
P1433
P1476
Programed death-1/programed de ...... med death-ligand 1 (Avelumab).
@en
P2093
Amanda L Gill
Cecile Le Saout
Helen Sabzevari
Jean-Marie Cuillerot
Jeffrey Lifson
Marta Catalfamo
Michael C Sneller
Refika Turnier
P2860
P304
P356
10.1097/QAD.0000000000001217
P407
P577
2016-08-03T00:00:00Z